This guideline provides recommendations for the use of PET imaging in gliomas. The review examines established clinical benefit in glioma patients of PET using glucose (18F-FDG) and amino acid tracers (11C-MET, 18F-FET, and 18F-FDOPA). An increasing number of studies have been published on PET imaging in the setting of diagnosis, biopsy, and resection as well radiotherapy planning, treatment monitoring, and response assessment. Recommendations are based on evidence generated from studies which validated PET findings by histology or clinical course. This guideline emphasizes the clinical value of PET imaging with superiority of amino acid PET over glucose PET and provides a framework for the use of PET to assist in the management of patients...
Introduction: Today, magnetic resonance imaging (MRI) is the standard method for monitoring patients...
PET imaging is being increasingly used to supplement MRI in the clinical management of brain tumors....
The most common type of primary brain tumor is malignant glioma. Despite intensive therapeutic effor...
This guideline provides recommendations for the use of PET imaging in gliomas. The review examines e...
This guideline provides recommendations for the use of PET imaging in gliomas. The review examines e...
International audiencePositron emission tomography (PET) is a nuclear medicine imaging method with i...
These joint practice guidelines, or procedure standards, were developed collaboratively by the Europ...
The management of patients with glioma usually requires multimodality treatment including surgery, r...
These joint practice guidelines, or procedure standards, were developed collaboratively by the Europ...
Neuroimaging enables the noninvasive evaluation of glioma and is considered to be one of the key fac...
The Response Assessment in Neuro-Oncology Working Group has analysed the role of clinically establis...
Introduction: Today, magnetic resonance imaging (MRI) is the standard method for monitoring patients...
PET imaging is being increasingly used to supplement MRI in the clinical management of brain tumors....
The most common type of primary brain tumor is malignant glioma. Despite intensive therapeutic effor...
This guideline provides recommendations for the use of PET imaging in gliomas. The review examines e...
This guideline provides recommendations for the use of PET imaging in gliomas. The review examines e...
International audiencePositron emission tomography (PET) is a nuclear medicine imaging method with i...
These joint practice guidelines, or procedure standards, were developed collaboratively by the Europ...
The management of patients with glioma usually requires multimodality treatment including surgery, r...
These joint practice guidelines, or procedure standards, were developed collaboratively by the Europ...
Neuroimaging enables the noninvasive evaluation of glioma and is considered to be one of the key fac...
The Response Assessment in Neuro-Oncology Working Group has analysed the role of clinically establis...
Introduction: Today, magnetic resonance imaging (MRI) is the standard method for monitoring patients...
PET imaging is being increasingly used to supplement MRI in the clinical management of brain tumors....
The most common type of primary brain tumor is malignant glioma. Despite intensive therapeutic effor...